Decreased plasma alpha-synuclein in idiopathic Parkinson's disease patients after adjusting hemolysis factor
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shim, Kyu Hwan | - |
dc.contributor.author | Kim, Seung Chan | - |
dc.contributor.author | Youn, Young Chul | - |
dc.contributor.author | Sung, Young-Hee | - |
dc.contributor.author | An, Seong Soo A. | - |
dc.date.accessioned | 2022-01-18T02:40:38Z | - |
dc.date.available | 2022-01-18T02:40:38Z | - |
dc.date.issued | 2020-11 | - |
dc.identifier.issn | 1738-642X | - |
dc.identifier.issn | 2092-8467 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/53684 | - |
dc.description.abstract | Background Lewy bodies are pathological hallmarks for the diagnosis of Parkinson's disease, where the core components are composed of aggregated forms of alpha-synuclein (alpha-syn). Although alpha-syn has been investigated as a potential biomarker for PD, its usage has been limited and still remains controversial. Objective An accurate enzyme-linked immunosorbent assay (ELISA) was developed for the detection of alpha-syn in plasma. The hemolysis score was calculated to eliminate the additive alpha-syn levels from RBCs. Human plasma samples were collected in heparinized blood tubes from idiopathic Parkinson disease (IPD) and healthy control (HC). Result Hemolysis score had a strong correlation with the level of plasma alpha-syn. From the limited set of samples in this preliminary study, decreased alpha-syn concentrations were observed in patients with IPD in comparison to HC after adjusting for hemolysis factor. Similar results with a commercial ELISA kit were found for measuring alpha-syn from the same set of samples with lower correlation and the reduced accuracy of diagnosis than the current study. Conclusion The adjustments for the hemolysis factor would be indispensable, supporting plasma alpha-syn as a potential surrogate biomarker for distinguishing IPD from HC. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREAN SOCIETY TOXICOGENOMICS & TOXICOPROTEOMICS-KSTT | - |
dc.title | Decreased plasma alpha-synuclein in idiopathic Parkinson's disease patients after adjusting hemolysis factor | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s13273-020-00104-7 | - |
dc.identifier.bibliographicCitation | MOLECULAR & CELLULAR TOXICOLOGY, v.16, no.4, pp 477 - 484 | - |
dc.identifier.kciid | ART002631296 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000569534700001 | - |
dc.identifier.scopusid | 2-s2.0-85090929477 | - |
dc.citation.endPage | 484 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 477 | - |
dc.citation.title | MOLECULAR & CELLULAR TOXICOLOGY | - |
dc.citation.volume | 16 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Parkinson's disease | - |
dc.subject.keywordAuthor | alpha-Synuclein | - |
dc.subject.keywordAuthor | Hemolysis | - |
dc.subject.keywordPlus | DRUG-NAIVE PATIENTS | - |
dc.subject.keywordPlus | CEREBROSPINAL-FLUID | - |
dc.subject.keywordPlus | CLINICAL-DIAGNOSIS | - |
dc.subject.keywordPlus | OLIGOMERIC FORMS | - |
dc.subject.keywordPlus | ELEVATED LEVELS | - |
dc.subject.keywordPlus | LEWY BODY | - |
dc.subject.keywordPlus | DEMENTIA | - |
dc.subject.keywordPlus | ACCURACY | - |
dc.subject.keywordPlus | CSF | - |
dc.subject.keywordPlus | BIOMARKER | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.